{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:22:00Z","timestamp":1781284920824,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T00:00:00Z","timestamp":1546128000000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA019497"],"award-info":[{"award-number":["R01DA019497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA07209"],"award-info":[{"award-number":["T32DA07209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsat.2016.12.006","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T04:49:23Z","timestamp":1482554963000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study"],"prefix":"10.1016","volume":"85","author":[{"given":"Brantley P.","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"DeFulio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-2418","authenticated-orcid":false,"given":"Lauren","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August F.","family":"Holtyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6153-5680","authenticated-orcid":false,"given":"Annie","family":"Umbricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Bigelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2016.12.006_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2015.10.003","article-title":"Extended-release naltrexone: A qualitative analysis of barriers to routine use","volume":"62","author":"Alanis-Hirsch","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.12.006_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2011.10.018","article-title":"Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose-effects and time-course","volume":"123","author":"Bigelow","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.12.006_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsat.2014.01.005","article-title":"A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence","volume":"46","author":"Bisaga","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.12.006_bb0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4088\/JCP.09m05080ecr","article-title":"Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: A quasi-experimental experiment","volume":"71","author":"Brooks","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2016.12.006_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.06.023","article-title":"Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial","volume":"120","author":"DeFulio","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.12.006_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/a0030743","article-title":"Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users","volume":"21","author":"Dunn","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2016.12.006_bb0035","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1360-0443.2011.03400.x","article-title":"Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: A randomized controlled trial","volume":"106","author":"Everly","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.12.006_bb0040","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1360-0443.2008.02252.x","article-title":"Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone","volume":"103","author":"Fishman","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.12.006_bb0045","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64years in the United States, 2003\u20132013","volume":"314","author":"Han","year":"2015","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2016.12.006_bb0050","series-title":"Morbidity and Mortality Weekly Report","first-page":"719","article-title":"Vital signs: Demographic and substance use trends among heroin users \u2013 United States, 2002-2013","volume":"64","author":"Jones","year":"2015"},{"key":"10.1016\/j.jsat.2016.12.006_bb0055","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1360-0443.2007.01817.x","article-title":"Overcoming opioid blockade from depot naltrexone (Prodetoxon\u00ae)","volume":"102","author":"Krupitsky","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.12.006_bb0060","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2016.12.006_bb0065","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1360-0443.2010.03031.x","article-title":"Challenges to antagonist blockade during sustained release naltrexone treatment","volume":"105","author":"Kun\u00f8e","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.12.006_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1369-1600.2012.00462.x","article-title":"Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients","volume":"19","author":"Langleben","year":"2012","journal-title":"Addiction Biology"},{"key":"10.1016\/j.jsat.2016.12.006_bb0075","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.12.006_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"4","author":"Minozzi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.12.006_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.12.006_bb0090","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/a0017074","article-title":"Ecological momentary assessment (EMA) in studies of substance use","volume":"21","author":"Shiffman","year":"2009","journal-title":"Psychological Assessment"},{"key":"10.1016\/j.jsat.2016.12.006_bb0095","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ypmed.2012.03.013","article-title":"Maintenance of reinforcement to address the chronic nature of drug addiction","volume":"55","author":"Silverman","year":"2012","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.jsat.2016.12.006_bb0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2013.05.030","article-title":"Naltrexone treatment for opioid dependence: Does its effectiveness depend on testing the blockade?","volume":"133","author":"Sullivan","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.12.006_bb0105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40263-013-0110-x","article-title":"Extended-release intramuscular naltrexone (Vivitrol\u00ae): A review of its use in the prevention of relapse to opioid dependence in detoxified patients","volume":"27","author":"Syed","year":"2013","journal-title":"CNS Drugs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216303725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216303725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:24Z","timestamp":1760039244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216303725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":21,"alternative-id":["S0740547216303725"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.12.006","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}